Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES

Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358

Genome-Wide Association Study of Peripheral Artery Disease.

van Zuydam NR. et al, (2021), Circ Genom Precis Med

Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study

Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011

Load More